Relevance of animal models for understanding mammalian copper homeostasis

American Journal of Clinical Nutrition

Volumn 88, Issue 3, 2008, Pages

  Vonk, Willianne I M ^a   Wijmenga, Cisca ^a,b   Van De Sluis, Bart ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COPPER; PROTEIN; TRACE ELEMENT;

CONFERENCE PAPER; COPPER METABOLISM; DISEASE MODEL; HOMEOSTASIS; INTOXICATION; MENKES SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; WILSON DISEASE; YEAST;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA; MUS; MUS MUSCULUS; OVIS ARIES;

EID: 51749083745     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/88.3.840s     Document Type: Conference Paper

References (45)

1. Prohaska JR, Gybina AA. Intracellular copper transport in mammals. J Nutr 2004;134:1003-6.
2. Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 1962;29:764-79.
3. van den Berghe PV, Folmer DE, Malingre HE, et al. Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake. Biochem J 2007;407:49-59.
4. Llanos RM, Mercer JF. The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol 2002;21:259-70.
5. Shim H, Harris ZL. Genetic defects in copper metabolism. J Nutr 2003;133:1527S-31S.
6. Kaler SG. Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. Am J Clin Nutr 1998;67:1029S-34S.
7. Harrison MD, Dameron CT. Molecular mechanisms of copper metabolism and the role of the Menkes disease protein. J Biochem Mol Toxicol 1999;13:93-106.
8. Mercer JF, Ambrosini L, Horton S, Gazeas S, Grimes A. Animal models of Menkes disease. Adv Exp Med Biol 1999;448:97-108.
9. Phillips M, Camakaris J, Danks DM. Comparisons of copper deficiency states in the murine mutants blotchy and brindled. Changes in copper-dependent enzyme activity in 13-day-old mice. Biochem J 1986;238:177-83.
10. Mercer JF. Menkes syndrome and animal models. Am J Clin Nutr 1998;67:1022S-8S.
11. Levinson B, Vulpe C, Elder B, et al. The mottled gene is the mouse homologue of the Menkes disease gene. Nat Genet 1994;6:369-73.
12. Grimes A, Hearn CJ, Lockhart P, Newgreen DF, Mercer JF. Molecular basis of the brindled mouse mutant (Mo(br)): a murine model of Menkes disease. Hum Mol Genet 1997;6:1037-42.
13. Camakaris J, Phillips M, Danks DM, Brown R, Stevenson T. Mutations in humans and animals which affect copper metabolism. J Inherit Metab Dis 1983;6(suppl 1):44-50.
14. Hamza I, Faisst A, Prohaska J, Chen J, Gruss P, Gitlin JD. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc Natl Acad Sci U S A 2001;98:6848-52.
15. Kuo YM, Zhou B, Cosco D, Gitschier J. The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc Natl Acad Sci U S A 2001;98:6836-41.
16. Lee J, Prohaska JR, Thiele DJ. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc Natl Acad Sci U S A 2001;98:6842-7.
17. Nose Y, Kim BE, Thiele DJ. Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metab 2006;4:235-44.
18. Theophilos MB, Cox DW, Mercer JF. The toxic milk mouse is a murine model of Wilson disease. Hum Mol Genet 1996;5:1619-24.
19. Buiakova OI, Xu J, Lutsenko S, et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet 1999;8:1665-71.
20. Li Y, Togashi Y, Sato S, et al. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Invest 1991;87:1858-61.
21. Wu J, Forbes JR, Chen HS, Cox DW. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 1994;7:541-5.
22. van De Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet 2002;11:165-73.
23. van de Sluis B, Muller P, Duran K, et al. Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice. Mol Cell Biol 2007;27:4142-56.
24. Haywood S, Muller T, Muller W, Heinz-Erian P, Tanner MS, Ross G. Copper-associated liver disease in North Ronaldsay sheep: a possible animal model for non-Wilsonian hepatic copper toxicosis of infancy and childhood. J Pathol 2001;195:264-9.
25. Takahashi Y, Kako K, Kashiwabara S, et al. Mammalian copper chaperone Cox17p has an essential role in activation of cytochrome C oxidase and embryonic development. Mol Cell Biol 2002;22:7614-21.
26. Wong PC, Waggoner D, Subramaniam JR, et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci U S A 2000;97:2886-91.
27. Prohaska JR, Geissler J, Brokate B, Broderius M. Copper, zinc-superoxide dismutase protein but not mRNA is lower in copper-deficient mice and mice lacking the copper chaperone for superoxide dismutase. Exp Biol Med (Maywood) 2003;228:959-66.
28. Michalska AE, Choo KH. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci U S A 1993;90:8088-92.
29. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A 1994;91:584-8.
30. Kim BE, Petris MJ. Phenotypic diversity of Menkes disease in mottled mice is associated with defects in localization and trafficking of the ATP7A protein. J Med Genet 2007;44:641-6.
31. Medici V, Rossaro L, Sturniolo GC. Wilson disease - a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis 2007;39:601-9.
32. Huster D, Purnat TD, Burkhead JL, et al. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem 2007;282:8343-55.
33. Muller T, Feichtinger H, Berger H, Muller W. Endemic Tyrolean infantile cirrhosis: an ecogenetic disorder. Lancet 1996;347:877-80.
34. Simpson DM, Mobasheri A, Haywood S, Beynon RJ. A proteomics study of the response of North Ronaldsay sheep to copper challenge. BMC Vet Res 2006;2:36.
35. de Bie P, van de Sluis B, Burstein E, et al. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology 2007;133:1316-26.
36. Lovicu M, Dessi V, Lepori MB, et al. The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease. J Gastroenterol 2006;41:582-7.
37. Stuehler B, Reichert J, Stremmel W, Schaefer M. Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients. J Mol Med 2004;82:629-34.
38. Weiss KH, Merle U, Schaefer M, Ferenci P, Fullekrug J, Stremmel W. Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels. World J Gastroenterol 2006;12:2239-42.
39. Muller T, van de Sluis B, Zhernakova A, et al. The canine copper toxicosis gene MURR1 does not cause non-Wilsonian hepatic copper toxicosis. J Hepatol 2003;38:164-8.
40. van de Sluis B, Groot AJ, Wijmenga C, Vooijs M, Klomp LW. COMMD1: a novel protein involved in the proteolysis of proteins. Cell Cycle 2007;6:2091-8.
41. West EC, Prohaska JR. Cu,Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice. Exp Biol Med (Maywood) 2004;229:756-64.
42. Prohaska JR, Broderius M. Plasma peptidylglycine alpha-amidating monooxygenase (PAM) and ceruloplasmin are affected by age and copper status in rats and mice. Comp Biochem Physiol B Biochem Mol Biol 2006;143:360-6.
43. Araya M, Olivares M, Pizarro F, Gonzalez M, Speisky H, Uauy R. Copper exposure and potential biomarkers of copper metabolism. Biometals 2003;16:199-204.
44. Suazo M, Olivares F, Mendez MA, et al. CCS and SOD1 mRNA are reduced after copper supplementation in peripheral mononuclear cells of individuals with high serum ceruloplasmin concentration. J Nutr Biochem 2008;19:269-74.
45. Mendelsohn BA, Yin C, Johnson SL, Wilm TP, Solnica-Krezel L, Gitlin JD. Atp7a determines a hierarchy of copper metabolism essential for notochord development. Cell Metab 2006;4:155-62.